|
|
||||||||


*
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190;
American Red Cross, National Histocompatibility Laboratory, Baltimore, MD 21201; and
National Marrow Donor Program, Minneapolis, MN 55413
Although extensive HLA-A and HLA-B polymorphism is evident, the
true diversity of HLA-C has remained hidden due to poor resolution of
HLA-C Ags. To better understand the polymorphic nature of HLA-C
molecules, 1823 samples from the National Marrow Donor Program research
repository in North America have been typed by DNA sequencing and
interpreted in terms of HLA-C diversification. Results show that
HLA-Cw*0701 was the most common allele with a frequency of 16%,
whereas 28% of the alleles typed as Cw12-18 (serologic blanks). The
frequency of homozygotes was 9.8% as compared with previous studies of
18% for sequence-specific primers and 50% for serology. Most
startling was the frequency at which new alleles were detected; 19 new
HLA-C alleles were detected, representing a rate of
1 in 100 samples
typed. These new HLA-C alleles result from 29 nucleotide substitutions
of which 4 are silent, such that coding substitutions concentrated
about the Ag-binding groove predominate. Polymorphism at the HLA-C
locus therefore resembles that at the HLA-A and HLA-B loci more than
previously believed, indicating that antigenic stress is driving HLA-C
evolution. However, sequence conservation in the
-helix of the first
domain and a clustering of unique amino acids around the B pocket
indicate that HLA-C alleles respond to antigenic pressures differently
than HLA-A and HLA-B. Finally, because the samples characterized were
predominantly from Caucasians, we hypothesize that HLA-C polymorphism
will equal or exceed that of the HLA-A and -B loci as DNA
sequence-based typing is extended to include more non-Caucasian
individuals.
This article has been cited by other articles:
![]() |
C. Geldmacher, I. S. Metzler, S. Tovanabutra, T. E. Asher, E. Gostick, D. R. Ambrozak, C. Petrovas, A. Schuetz, N. Ngwenyama, G. Kijak, et al. Minor viral and host genetic polymorphisms can dramatically impact the biologic outcome of an epitope-specific CD8 T-cell response Blood, August 20, 2009; 114(8): 1553 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geldmacher, J. R. Currier, E. Herrmann, A. Haule, E. Kuta, F. McCutchan, L. Njovu, S. Geis, O. Hoffmann, L. Maboko, et al. CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients J. Virol., March 1, 2007; 81(5): 2440 - 2448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tang, S. Tang, E. Lobashevsky, A. D. Myracle, U. Fideli, G. Aldrovandi, S. Allen, R. Musonda, and R. A. Kaslow Favorable and Unfavorable HLA Class I Alleles and Haplotypes in Zambians Predominantly Infected with Clade C Human Immunodeficiency Virus Type 1 J. Virol., July 19, 2002; 76(16): 8276 - 8284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Kaslow, C. Rivers, J. Tang, T. J. Bender, P. A. Goepfert, R. El Habib, K. Weinhold, M. J. Mulligan, and the NIAID Aids Vaccine Evaluation Group Polymorphisms in HLA Class I Genes Associated with both Favorable Prognosis of Human Immunodeficiency Virus (HIV) Type 1 Infection and Positive Cytotoxic T-Lymphocyte Responses to ALVAC-HIV Recombinant Canarypox Vaccines J. Virol., September 15, 2001; 75(18): 8681 - 8689. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Rinaldo Jr., X.-L. Huang, Z. Fan, J. B. Margolick, L. Borowski, A. Hoji, C. Kalinyak, D. K. McMahon, S. A. Riddler, W. H. Hildebrand, et al. Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeficiency J. Virol., May 1, 2000; 74(9): 4127 - 4138. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |